Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

PTIUpdated: Tuesday, June 22, 2021, 11:11 AM IST
article-image
Dr Reddy’s Laboratories exploring legal options after asked to pay $46.25 mn to Hatchtech Pty |

Dr Reddy's Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

The company has launched Icosapent Ethyl Capsules in 1 gram strength after approval by the US Food and Drug Administration (USFDA), Dr Reddy's said in a regulatory filing.

Dr Reddy''s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120''s count.

Dr Reddy's Icosapent Ethyl Capsules, 1 gram, is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Ashneer Grover and his wife get summoned by Delhi HC over vicious campaign against BhraratPe

Ashneer Grover and his wife get summoned by Delhi HC over  vicious campaign against BhraratPe

Landmark Cars' Rs 552 crore IPO to open on Dec 13

Landmark Cars' Rs 552 crore IPO to open on Dec 13

Twitter considering $11 for Blue service with verification for iPhone users

Twitter considering $11 for Blue service with verification for iPhone users

Urbanisation going to be the key, says NITI Aayog CEO

Urbanisation going to be the key, says NITI Aayog CEO

Japan's economy shrank less in July-Sept, data show

Japan's economy shrank less in July-Sept, data show